The BOSTON-1 and BOSTON-2 are Phase III studies designed to evaluate the safety and efficacy of investigational Liposomal Cyclosporine A (L-CsA-i) in patients with bronchiolitis obliterans syndrome (BOS) following a single or double lung transplant.
Study Overview
Study Overview
About BOS
About Clinical Trials
Locator Icon
Study Centers
Legal popup

This page is for US healthcare professionals only.

Are you a US healthcare professional?